Learn More From MICC and Myers Cocktail to B12, biotin, mineral blends, and high-dose vitamin C, our injections deliver essential nutrients directly where your body needs them most
In a landmark trial of 17,604 overweight and obese patients with heart disease, weekly injections of semaglutidethe active ingredient in Wegovy and its twin Ozempicfor an average of 33 months reduced the risk of heart attack, stroke, and death from cardiovascular causes by 20 percent compared with a placebo group
The efficacy of IDegLira (Insulin Degludec/Liraglutide combination) in adults with type 2 diabetes inadequately controlled with a GLP-1 receptor agonist and oral therapy: DUAL III randomized clinical trial
you are investing in a formulation designed to work with your body's natural biology
Scenario 1: significant weight loss (50 or more pounds to lose) Starting point: BMI 35+, 50 to 100+ pounds above healthy weight range
Establish your baseline before starting the combination, and set clear thresholds with your provider for when to contact them